Tropicamide/hydroxyamfetamine
(Redirected from Paremyd)
| Combination of | |
|---|---|
| Tropicamide | anticholinergic |
| Hydroxyamfetamine | sympathomimetic |
| Clinical data | |
| Trade names | Paremyd |
Tropicamide/hydroxyamfetamine (trade name Paremyd) is a combination drug used as an ophthalmic solution to induce mydriasis. It consists of:[1]
- Tropicamide (0.25%), an anticholinergic drug
- Hydroxyamfetamine (norpholedrine, 1%), a sympathomimetic drug
References
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Combination drugs
- Ophthalmology drugs
- All stub articles
- Pharmacology stubs